PMID- 28328533 OWN - NLM STAT- MEDLINE DCOM- 20180326 LR - 20180816 IS - 2191-0251 (Electronic) IS - 0334-018X (Linking) VI - 30 IP - 5 DP - 2017 May 1 TI - Plasma but not serum brain-derived neurotrophic factor concentration is decreased by oral glucose tolerance test-induced hyperglycemia in children. PG - 525-530 LID - /j/jpem.2017.30.issue-5/jpem-2016-0344/jpem-2016-0344.xml [pii] LID - 10.1515/jpem-2016-0344 [doi] AB - BACKGROUND: Little is known regarding the relationships among circulating brain-derived neurotrophic factor (BDNF) levels and glucose or insulin in children and adolescents. The objective of this study was to investigate whether circulating BDNF levels would change during the oral glucose tolerance test (OGTT). METHODS: We performed the OGTT and measured the serial changes in BDNF levels in both plasma and serum. RESULTS: There were 22 subjects in the normal type (N) group and 20 in the borderline/diabetic type (B/D) group, defined by the results of the OGTT. Serum levels of BDNF were almost five times higher and plasma levels gradually decreased during the OGTT, whereas serum levels showed no significant change. The reduction of plasma BDNF level changes from baseline to 120 min were significantly different between the N and B/D groups (36.3% vs. 20.8%, p=0.023). CONCLUSIONS: Our results showed that plasma levels of BDNF are more sensitive to acute changes in glucose or insulin levels than serum. FAU - Araki, Shunsuke AU - Araki S FAU - Yamamoto, Yukiyo AU - Yamamoto Y FAU - Saito, Reiko AU - Saito R FAU - Kawakita, Aoi AU - Kawakita A FAU - Eguchi, Mami AU - Eguchi M FAU - Goto, Motohide AU - Goto M FAU - Kubo, Kazuyasu AU - Kubo K FAU - Kawagoe, Rinko AU - Kawagoe R FAU - Kawada, Yasusada AU - Kawada Y FAU - Kusuhara, Koichi AU - Kusuhara K LA - eng PT - Journal Article PL - Germany TA - J Pediatr Endocrinol Metab JT - Journal of pediatric endocrinology & metabolism : JPEM JID - 9508900 RN - 0 (Biomarkers) RN - 0 (Blood Glucose) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Insulin) RN - 7171WSG8A2 (BDNF protein, human) SB - IM MH - Adolescent MH - Biomarkers/*blood MH - Blood Glucose/analysis MH - Brain-Derived Neurotrophic Factor/*blood MH - Child MH - Child, Preschool MH - Diabetes Mellitus, Type 2/complications/*physiopathology MH - Female MH - Glucose Tolerance Test/*adverse effects MH - Humans MH - Hyperglycemia/*etiology MH - Insulin/blood MH - Male OTO - NOTNLM OT - brain-derived neurotrophic factor OT - child and adolescents OT - glucose tolerance test OT - insulin OT - platelets EDAT- 2017/03/23 06:00 MHDA- 2018/03/27 06:00 CRDT- 2017/03/23 06:00 PHST- 2016/08/31 00:00 [received] PHST- 2017/02/02 00:00 [accepted] PHST- 2017/03/23 06:00 [pubmed] PHST- 2018/03/27 06:00 [medline] PHST- 2017/03/23 06:00 [entrez] AID - /j/jpem.2017.30.issue-5/jpem-2016-0344/jpem-2016-0344.xml [pii] AID - 10.1515/jpem-2016-0344 [doi] PST - ppublish SO - J Pediatr Endocrinol Metab. 2017 May 1;30(5):525-530. doi: 10.1515/jpem-2016-0344.